Genentech, Inc. - Company Profile and SWOT Analysis

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $175	62 Pages	MarketLine	December, 2024	MTLN19551927

Best Price Guarantee
Price	from $175
Length	62 Pages
Publisher	MarketLine
Published Date	December, 2024
SKU	MTLN19551927

Genentech, Inc. - Company Profile and SWOT Analysis

Summary

Genentech, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Genentech, Inc. (Genentech or ‘the company’), a subsidiary of Roche Group is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company’s medicines include Activase, Boniva Tablets, Cotellic, Erivedge, Fuzeon, Gazyva, Hemlibra, Invirase, Klonopin, Lucentis, Actemra, Nutropin AQ, Ocrevus, Tamiflu, Pegasys, Rituxan, Rocephin, Tecentriq, Polivy, Rozlytrek, Valium, Xeloda and Zelboraf. The company offers its products with a focus on the areas of oncology, immunology, neuroscience, metabolism, ophthalmology, and infectious disease. Genentech manages its manufacturing facilities and distribution center in California and Oregon, the US. The company is headquartered in South San Francisco, California, the US.

Scope

Detailed information on Genentech, Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Genentech, Inc. in the form of a SWOT analysis
An in-depth view of the business model of Genentech, Inc. including a breakdown and examination of key business segments
Intelligence on Genentech, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Genentech, Inc., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Genentech, Inc. and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Genentech, Inc. as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Genentech, Inc.'s business structure, strategy and prospects.

Company Snapshot: Genentech, Inc.: Company Overview; Genentech, Inc.: Overview and Key Facts; Genentech, Inc.: Overview; Genentech, Inc.: Key Facts; Genentech, Inc.: Key Employees; Genentech, Inc.: Major Products and Services; Genentech, Inc.: Company History; Genentech, Inc.: Key Competitors; Genentech, Inc.: Company Analysis; Genentech, Inc.: Business Description; Genentech, Inc.: SWOT Analysis; Genentech, Inc.: SWOT Overview; Genentech, Inc.: Strengths; Genentech, Inc.: Weaknesses; Genentech, Inc.: Opportunities; Genentech, Inc.: Threats; Genentech, Inc.: Corporate Financial Deals Activity; Genentech, Inc.: Financial Deals Overview; Genentech, Inc.: Targets and Partners; Genentech, Inc.: Top Deals 2020 - 2024YTD*; Genentech, Inc.: Advisors; Genentech, Inc.: Top Legal Advisors; Genentech, Inc.: Top Financial Advisors; Genentech, Inc.: Mergers and Acquisitions; Genentech, Inc.: Partnership; Genentech, Inc.: Recent Developments; Genentech, Inc.: News and Events Summary; Genentech, Inc.: Contracts; Genentech, Inc.: Financial Deals; Genentech, Inc.: Market Developments; Genentech, Inc.: Research & Development
Appendix: Contact Us; Methodology; About MarketLine
List of Tables: Table 1: Genentech, Inc.: Key Facts; Table 2: Genentech, Inc.: Key Employees; Table 3: Genentech, Inc.: Company History; Table 4: Genentech, Inc.: Key Competitors; Table 5: Genentech, Inc.: Deal Activity by Deal Type - Volume (TTM*); Table 6: Genentech, Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024); Table 7: Genentech, Inc.: M&A Average Deal Size - Value (US$m); Table 8: Genentech, Inc.: Targets and Partners; Table 9: Genentech, Inc.: Top Deals 2020 - 2024YTD*; Table 10: Genentech, Inc.: Legal Advisor Ranking by Value (US$m); Table 11: Genentech, Inc.: Financial Advisor Ranking by Value (US$m); Table 12: Genentech, Inc.: M&A Volume and Value Trend (2020 - YTD*2024); Table 13: Genentech, Inc.: Partnership Volume and Value Trend (2020 - YTD*2024); Table 14: Genentech, Inc.: Partnership Trend by Deal Type (2020 - YTD*2024); Table 15: Genentech, Inc.: News and Events Summary; Table 16: Genentech, Inc.: Contracts; Table 17: Genentech, Inc.: Financial Deals; Table 18: Genentech, Inc.: Market Developments; Table 19: Genentech, Inc.: Research & Development
List of Figures: Figure 1: Genentech, Inc.: Deal Activity by Deal Type - Volume (TTM*); Figure 2: Genentech, Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024); Figure 3: Genentech, Inc.: M&A Average Deal Size - Value (US$m); Figure 4: Genentech, Inc.: M&A Volume and Value Trend (2020 - YTD*2024); Figure 5: Genentech, Inc.: Partnership Volume and Value Trend (2020 - YTD*2024); Figure 6: Genentech, Inc.: Partnership Trend by Deal Type (2020 - YTD*2024)